Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 7, 2014; 20(25): 8018-8023
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8018
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8018
Liver fibrosis markers in alcoholic liver disease
Lech Chrostek, Department of Biochemical Diagnostics, Medical University of Bialystok, 15-540 Bialystok, Poland
Anatol Panasiuk, Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Bialystok, Poland
Author contributions: Chrostek L and Panasiuk A solely contributed to this paper.
Correspondence to: Anatol Panasiuk, Professor, Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Zurawia 15, 15-540 Bialystok, Poland. anatol@panasiuk.pl
Telephone: +48-85-7409491 Fax: +48-85-7416921
Received: October 29, 2013
Revised: November 25, 2013
Accepted: January 3, 2014
Published online: July 7, 2014
Processing time: 247 Days and 12.2 Hours
Revised: November 25, 2013
Accepted: January 3, 2014
Published online: July 7, 2014
Processing time: 247 Days and 12.2 Hours
Core Tip
Core tip: Monitoring the stage of liver fibrosis in alcohol abusing persons is important in order to undertake proper therapeutic decisions. The usefulness of liver biopsy in the diagnostics of liver fibrosis is indisputable with the only limitation being its invasive character. Thus, non-invasive tests and biochemical markers determining the stage and dynamics of liver fibrosis in alcohol liver disease are of great significance.